Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

8.07
Delayed Data
As of 3:55pm ET
 +0.405 / +5.29%
Today’s Change
7.29
Today|||52-Week Range
18.48
-43.00%
Year-to-Date

Today’s Trading

Previous close7.66
Today’s open7.81
Day’s range7.41 - 8.31
Volume2,712,817
Average volume (3 months)1,761,850
Market cap$793.5M
Dividend yield--
Data as of 3:55pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+23.40%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book9.66

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...0.000.00%
LXRXLexicon Pharmaceutic...+0.33+3.98%
NXTMNxStage Medical Inc+0.07+0.51%
SGMOSangamo BioSciences ...+0.30+3.38%
Data as of 3:55pm ET, 07/28/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers